Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression - prognosis - immune microenvironment - and immunotherapy response
Favorite
Share
More Options
25

Open in WPS to view all 25 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
